Sponsors (7)
The bill aims to improve investigations and transparency to curb deadly synthetic-drug distribution, but it does so by mandating extensive data collection and preservation that raise substantial privacy, surveillance, and compliance-cost risks for users, providers, and civil liberties.
People at risk of overdose and the general public: could see reduced distribution of deadly synthetic drugs (fentanyl, methamphetamine, counterfeit pills) as faster investigations and prosecutions disrupt supply networks.
Law enforcement agencies and prosecutors: gain timelier reports and preserved electronic evidence to investigate and prosecute distribution networks for fentanyl, methamphetamine, and counterfeit drugs.
Taxpayers and oversight bodies: receive annual Department of Justice reports that increase transparency about how the program is used, including report volumes, sources, and outcomes.
Users (including marginalized groups), journalists, and security researchers: would face increased privacy risks because providers must collect and disclose extensive user metadata and account identifiers, and mandatory preservation/disclosure could expose encrypted, journalistic, or privileged communications and chill lawful speech or security research.
Technology providers and their customers: could incur substantial financial and operational burdens from compliance, including risk of large civil and criminal penalties for noncompliance, which may raise costs for users or reduce available services.
Users, tech workers, and taxpayers: could face broader surveillance incentives and heavier reliance on automated detection, producing false positives, extra burdens on providers to review reports, and potential misuse of reported data.
Based on analysis of 3 sections of legislative text.
Requires electronic communication and remote computing providers to report suspected fentanyl, meth, counterfeit drugs, and illicit prescription-drug activity to the Attorney General, preserve records, and assist law enforcement.
Introduced July 17, 2025 by Roger Wayne Marshall · Last progress July 17, 2025
Requires electronic communication and remote computing service providers to report to the Attorney General when they know or reasonably believe their services are being used for crimes involving fentanyl, methamphetamine, counterfeit drugs (including fake prescription drugs), or unauthorized manufacture/distribution/dispensing of prescription pain medications or stimulants. The bill also requires providers to preserve and produce subscriber and content records, assist law enforcement under specified procedures, and subjects noncompliant providers to civil penalties and injunctive relief while stating that constitutional protections and statutory privileges remain in effect. The measure directs the Attorney General to issue implementing regulations within set timeframes, establishes notice and emergency-disclosure procedures for law enforcement requests, and contains a severability clause so the rest of the law stays in effect if part is found unconstitutional.